Search

Search Results
Results 10181 - 10190 of 10206 for Brain Cancer
  • Meloxicam Viatris
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Meloxicam Viatris (Meloxicam) intended for persons living in Australia.
  • Eating Disorders Diagnosis
    Health - 19 Jun 2023
    Diagnosis of eating disorders is a process that begins with acceptance of its presence. Often the patient needs to be convinced of its presence as there is severe denial and resistance to the problem.
  • Norimin
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Norimin intended for persons living in Australia.
  • Norimin-1
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Norimin-1 intended for persons living in Australia.
  • Zan-Extra
    Drug - 24 Feb 2023
    Consumer Medicine Information (CMI) about Zan-Extra intended for persons living in Australia.
  • Everything You Need To Know About Sepsis
    Health - 21 Feb 2023
    Sepsis is a life-threatening systemic response to an infection. This article provides an overview of sepsis, including stages, diagnosis and treatment.
  • Solian
    Drug - 16 Feb 2023
    Consumer Medicine Information (CMI) about Solian intended for persons living in Australia.
  • Imatinib-Teva
    Drug - 9 Jan 2023
    Consumer Medicine Information (CMI) about Imatinib-Teva intended for persons living in Australia.
  • Genotropin
    Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Genotropin intended for persons living in Australia.
  • Genotropin MiniQuick
    Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Genotropin MiniQuick intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback